Logo 1.JPG
The U.S. Digital Therapeutics Market is Expected to Reach $8.8 Billion by 2027 - Arizton
10 juin 2022 15h05 HE | Arizton Advisory and Intelligence
Chicago, June 10, 2022 (GLOBE NEWSWIRE) -- According to Arizton’s latest research report, the U.S. digital therapeutics market is expected to grow at a CAGR of 33.15% during 2022-2027. The digital...
logomdc.png
CNS Digital Therapeutics Market to grow at a 31.6% CAGR from 2022 to 2030 - MDC Research
19 avr. 2022 13h16 HE | Market Data Centre
Pune, April 19, 2022 (GLOBE NEWSWIRE) -- The CNS digital therapeutics market is driven by increasing prevalence of neurological disorders, the growing geriatric population that in turn increases the...
22157.jpg
Worldwide Digital Therapeutics Industry to 2026 - Huge Undiagnosed and Untreated Population Base Presents Opportunities
20 déc. 2021 09h33 HE | Research and Markets
Dublin, Dec. 20, 2021 (GLOBE NEWSWIRE) -- The "Digital Therapeutics Market Research Report by Indication, Component, Distribution, and Region - Global Forecast to 2026 - Cumulative Impact of...
FBI LOGO TM.png
Autism Spectrum Disorder Therapeutics Market worth USD 5.15 Billion by 2028 | Market Projection By Technology, Major key players, Growth, Revenue, CAGR, Regional Analysis, Industry Forecast To 2028
29 oct. 2021 05h28 HE | Fortune Business Insights
Pune, India, Oct. 29, 2021 (GLOBE NEWSWIRE) -- The global autism spectrum disorder therapeutics market size is expected to be worth USD 5.15 billion by 2028. The market size was USD 3.62 billion in...
ReportLinker logo.jpg
The global digital therapeutics market is projected to reach USD 13.1 billion by 2026 from USD 3.4billion in 2021, at a CAGR of 31.4%
22 juil. 2021 05h07 HE | ReportLinker
New York, July 22, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Digital Therapeutics Market by Application, Sales Channel - Global Forecasts to 2026" -...
Cognoa Seeks FDA Cle
Cognoa Seeks FDA Clearance for Breakthrough Digital Autism Diagnostic Device After Successful Pivotal Study
23 sept. 2020 09h03 HE | Cognoa
Palo Alto, Calif., Sept. 23, 2020 (GLOBE NEWSWIRE) -- Cognoa, the leading pediatric behavioral health company developing diagnostic and therapeutic solutions for children living with autism and...
ReportLinker logo.jpg
United States Digital Therapeutics Market By Product, By Sales Channel, By Application, By Region, Forecast & Opportunities, 2025
03 juil. 2020 07h27 HE | ReportLinker
New York, July 03, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "United States Digital Therapeutics Market By Product, By Sales Channel, By Application, By Region,...
22157.jpg
United States Digital Therapeutics Market (2019 to 2025) - By Product, By Sales Channel, By Application, By Region, Forecast & Opportunities
26 mai 2020 04h58 HE | Research and Markets
Dublin, May 26, 2020 (GLOBE NEWSWIRE) -- The "United States Digital Therapeutics Market By Product (Software v/s Device), By Sales Channel (B2B v/s B2C), By Application (Preventive Applications...
22157.jpg
World Digital Therapeutics (DTx) Market Insights, 2020 Featuring Wellthy Therapeutics, Welldoc, Proteus Digital Health, Propeller Health, Pear Therapeutics, and More
27 avr. 2020 05h53 HE | Research and Markets
Dublin, April 27, 2020 (GLOBE NEWSWIRE) -- The "Global Digital Therapeutics (DTx) Market Analysis & Trends - Industry Forcast to 2028" report has been added to ResearchAndMarkets.com's...
Cognoa Appoints Industry Leader David Happel as New Chief Executive Officer
24 mars 2020 06h05 HE | Cognoa
Palo Alto, Calif., March 24, 2020 (GLOBE NEWSWIRE) -- Cognoa, the leading digital therapeutics company focused on pediatric behavioral health, announced today the appointment of David Happel as...